Methylphenidate Hydrochloride

CAS 23655-65-4 21 current records 4 historicalSmall Molecule

Who holds supplier records for Methylphenidate Hydrochloride? 21 organisations hold a current record for Methylphenidate Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 15 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), United States (5), United Kingdom (1), Germany (1) and 4 other countries (4); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Methylphenidate Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/methylphenidate-hydrochloride

Reading the evidence

  • 21 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (21)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Methylphenidate Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Methylphenidate Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (15)

Certificates of Suitability on the EDQM register for Methylphenidate Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MALLADI DRUGS AND PHARMACEUTICALS LIMITED RanipetIN
CEP 2026-178 - Rev 00
Methylphenidate hydrochloride
Nov 2026—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2009-359 - Rev 03
Methylphenidate hydrochloride
Oct 2026—
VERANOVA, L.P. West DeptfordUS
CEP 2017-119 - Rev 02
Methylphenidate hydrochloride
Mar 2026—
ARENE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2025-151 - Rev 00
Methylphenidate hydrochloride
Oct 2025—
JANSSEN PHARMACEUTICA NV BeerseBE
CEP 2024-590 - Rev 00
Methylphenidate hydrochloride, Process II
May 2025Inspected Jun 2026
Belgium
HARMAN FINOCHEM LIMITED MumbaiIN
CEP 2021-474 - Rev 01
Methylphenidate hydrochloride, Process II
Jan 2025—
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2017-181 - Rev 02
Methylphenidate hydrochloride
Dec 2024—
CENTAUR PHARMACEUTICALS PRIVATE LIMITED MumbaiIN
CEP 2021-119 - Rev 02
Methylphenidate hydrochloride
Nov 2024—
SPECGX LLC Webster GrovesUS
CEP 2020-005 - Rev 01
Methylphenidate hydrochloride, Process II, Non-fine (Code 0570) and Fine (Code 1335)
Oct 2024—
NORAMCO, LLC. WilmingtonUS
CEP 2018-030 - Rev 04
Methylphenidate hydrochloride
Sept 2024—
SCI PHARMTECH, INC. Taoyuan CityTW
R1-CEP 2012-168 - Rev 01
Methylphenidate hydrochloride
Sept 2022—
LABORATORIOS RUBIO, S.A. CastellbisbalES
R1-CEP 2016-073 - Rev 00
Methylphenidate hydrochloride
Mar 2022—
SIEGFRIED EVIONNAZ SA EvionnazCH
R1-CEP 2011-378 - Rev 01
Methylphenidate hydrochloride
Oct 2018—
IPCA Laboratories Limited MumbaiIN
R1-CEP 2009-094 - Rev 00
Methylphenidate hydrochloride
Aug 2015—
MACFARLAN SMITH LIMITED EdinburghGB
R1-CEP 2009-078 - Rev 00
Methylphenidate hydrochloride
Jan 2015—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Methylphenidate Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • CODY LABORATORIES INC
    Inactive DMF 33509 · filed Mar 2019
  • BOEHRINGER INGELHEIM CHEMICALS INC
    Inactive DMF 15485 · filed Jun 2001
  • Inactive DMF 11635 · filed Aug 1995
  • CIBA GEIGY CORP PHARMACEUTICAL DIVISION
    Inactive DMF 4599 · filed Jun 1982

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Methylphenidate Hydrochloride is a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing levels of certain neurotransmitters in the brain.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Central Nervous System Stimulant
Physiologic effect
Central Nervous System Stimulation

Therapeutic areas

Attention Deficit Hyperactivity Disorder (ADHD)Narcolepsy

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Methylphenidate Hydrochloride?

21 organisations hold an active US FDA Type II Drug Master File or a CEP for Methylphenidate Hydrochloride: NORAMCO INC (United States), SPECGX LLC (United States), JANSSEN RESEARCH AND DEVELOPMENT LLC (United States), VERANOVA LP (United Kingdom), Alkem Laboratories Limited (India), CAMBREX CHARLES CITY INC (United States), CHATTEM CHEMICALS INC (United States) and CURIA MISSOURI INC, and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Methylphenidate Hydrochloride Drug Master Files are active?

NORAMCO INC (DMF 22244, 27208), SPECGX LLC (DMF 12769, 25776), JANSSEN RESEARCH AND DEVELOPMENT LLC (DMF 30546, 30510), VERANOVA LP (DMF 19547, 10137), Alkem Laboratories Limited (DMF 30682), CAMBREX CHARLES CITY INC (DMF 16610), CHATTEM CHEMICALS INC (DMF 16331) and CURIA MISSOURI INC (DMF 19063) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Methylphenidate Hydrochloride records mean?

4 organisations have only inactive Type II DMFs for Methylphenidate Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Methylphenidate Hydrochloride have a European Certificate of Suitability?

Yes. 15 organisations hold a valid CEP for Methylphenidate Hydrochloride on the EDQM register, including MALLADI DRUGS AND PHARMACEUTICALS LIMITED Ranipet (IN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), VERANOVA, L.P. West Deptford (US), ARENE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), JANSSEN PHARMACEUTICA NV Beerse (BE) and HARMAN FINOCHEM LIMITED Mumbai (IN) and 9 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Methylphenidate Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Methylphenidate Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.